Business Insight Journal Interview with Daniel Vitt, Ph.D., Chief Executive Officer, Immunic
A perspective on advancing oral therapies, managing clinical risk, and building long-term value in autoimmune and inflammatory disease research. Dr. Vitt, you’ve had a remarkable...